| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/03/2001 | WO2001030846A1 Beta-defensins |
| 05/03/2001 | WO2001030845A1 Pablo, a polypeptide that interacts with bcl-xl, and uses related thereto |
| 05/03/2001 | WO2001030844A1 Dna encoding human alpha1g-c t-type calcium channel |
| 05/03/2001 | WO2001030843A1 Ligand activated transcriptional regulator proteins |
| 05/03/2001 | WO2001030842A1 A new polypeptide-zinc finger protein 36 and the polynucleotide encoding it |
| 05/03/2001 | WO2001030841A1 A new polypeptide-zinc finger protein 60 and the polynucleotide encoding it |
| 05/03/2001 | WO2001030840A1 A new polypeptide-zinc finger protein 57 and the polynucleotide encoding it |
| 05/03/2001 | WO2001030839A1 A novel polypeptide-human rna-binding protein 33 and a polynucleotide encoding the same |
| 05/03/2001 | WO2001030837A1 A novel polypeptide - human galectin 15 and a polynucleotide encoding the same |
| 05/03/2001 | WO2001030836A1 Novel human atpases and encoding sequences thereof |
| 05/03/2001 | WO2001030834A1 A new polypeptide-zinc finger protein 33 and the polynucleotide encoding it |
| 05/03/2001 | WO2001030832A1 A new polypeptide-zinc finger protein hkznf-23 and the polynucleotide encoding it |
| 05/03/2001 | WO2001030831A1 Secreted proteins and uses thereof |
| 05/03/2001 | WO2001030829A1 A novel human metabotropic glutamate receptor |
| 05/03/2001 | WO2001030828A1 Therapeutic compositions and methods for treating disease states with mutant forms of myeloid progenitor inhibitory factor-2 (mpif-2) |
| 05/03/2001 | WO2001030827A1 A novel polypeptide-zinc finger protein 56 and polynucleotide encoding said polypeptide |
| 05/03/2001 | WO2001030826A1 A novel polypeptide-serine/threonine kinase 29 and polynucleotide encoding said polypeptide |
| 05/03/2001 | WO2001030825A1 A novel polypeptide-human splicing factor 25 and the polynucleotide encoding said polypeptide |
| 05/03/2001 | WO2001030824A1 A novel polypeptide-nadp hydrogenase subunit 50 and the polynucleotide encoding said polypeptide |
| 05/03/2001 | WO2001030823A1 A novel polypeptide-human circular canal protein 69 and the polynucleotide encoding said polypeptide |
| 05/03/2001 | WO2001030821A1 A novel polypeptide-homo rna cyclase 41 and polynucleotide encoding said polypeptide |
| 05/03/2001 | WO2001030820A1 A novel polypeptide-zinc finger protein 54 and polynucleotide encoding said polypeptide |
| 05/03/2001 | WO2001030819A1 A novel polypeptide-human tropomodulin 39 and the polynucleotide encoding said polypeptide |
| 05/03/2001 | WO2001030818A1 A novel polypeptide-rna binding protein 33 and polynucleotide encoding said polypeptide |
| 05/03/2001 | WO2001030817A1 Immunogenic proteins from the domestic mite, blomia tropicalis |
| 05/03/2001 | WO2001030816A1 NON-ANAPHYLACTIC FORMS OF GRASS POLLEN Ph1 p 6 ALLERGEN AND THEIR USE |
| 05/03/2001 | WO2001030813A1 Novel molecules of the card-related protein family and uses thereof |
| 05/03/2001 | WO2001030811A2 Complex comprising an igfiie polypeptide-fragment and an igfbp2 polypeptide and its use in the treatment of osteoporosis |
| 05/03/2001 | WO2001030810A2 Relaxase and other vir proteins as targets for treatment of helicobacter pylori infection and as dna transfer system to mammalian cells |
| 05/03/2001 | WO2001030809A1 Cyclic peptides and aids vaccines |
| 05/03/2001 | WO2001030808A1 Methods and compounds for modulating melanocortin receptor-ligand binding |
| 05/03/2001 | WO2001030806A1 Polynucleotides and polypeptides involved in biofilm biology and their uses |
| 05/03/2001 | WO2001030804A2 Salt form of a conjugate useful in the treatment of prostate cancer |
| 05/03/2001 | WO2001030802A2 Therapeutic treatments comprising administration of certain steroids for blood cell deficiencies |
| 05/03/2001 | WO2001030800A1 Antisense modulation of y-box binding protein 1 expression |
| 05/03/2001 | WO2001030797A1 Antisense modulation of methionine aminopeptidase 2 expression |
| 05/03/2001 | WO2001030795A1 Hygromycin derivatives |
| 05/03/2001 | WO2001030395A1 Antisense modulation of tumor necrosis factor alpha converting enzyme (tace) expression |
| 05/03/2001 | WO2001030394A1 Treatment of cancer |
| 05/03/2001 | WO2001030393A2 Methods for reducing the effects of cancers that express a33 antigen using a33 antigen specific immunoglobulin products |
| 05/03/2001 | WO2001030392A2 Delivery of proteins across polar epithelial cell layers |
| 05/03/2001 | WO2001030389A1 Wound contraction inhibitors |
| 05/03/2001 | WO2001030388A1 Tension-relieving agents for ciliary muscle |
| 05/03/2001 | WO2001030383A2 Medicament in order to induce tolerance |
| 05/03/2001 | WO2001030382A1 Method of inducing and/or enhancing an immune response to tumor antigens |
| 05/03/2001 | WO2001030380A2 Methods and compositions for treatment of keratoconus using protease inhibitors |
| 05/03/2001 | WO2001030379A2 Compositions and methods for preventing and treating transplant rejection |
| 05/03/2001 | WO2001030377A1 Porcine b7-1 and antibodies thereto |
| 05/03/2001 | WO2001030376A2 Use of urodilatin for treating chronic kidney failure with residual kidney functions |
| 05/03/2001 | WO2001030375A2 Use of gdnf for treating corneal defects |
| 05/03/2001 | WO2001030374A1 Stem cell engraftment-enhancing cellular proteins and their uses |
| 05/03/2001 | WO2001030373A1 Polypeptide composition |
| 05/03/2001 | WO2001030372A2 Pharmaceutical agent preparations |
| 05/03/2001 | WO2001030371A2 Novel chimeric analgesic peptides |
| 05/03/2001 | WO2001030370A1 Methods of treating vascular disease associated with cystatin c deficiency |
| 05/03/2001 | WO2001030369A1 Process for inducing immunological tolerance for xenogeneic transplants |
| 05/03/2001 | WO2001030368A1 Method for pr-39 peptide regulated stimulation of angiogenesis |
| 05/03/2001 | WO2001030362A2 Ribozyme therapy for the treatment of proliferative skin and eye diseases |
| 05/03/2001 | WO2001030361A1 Antisense modulation of cytohesin-2expression |
| 05/03/2001 | WO2001030360A1 Modulation of l-selectin shedding via inhibition of tumor necrosis factor alpha converting enzyme (tace) |
| 05/03/2001 | WO2001030357A1 Hormonal composition based on a progesterone and an oestrogen and use thereof |
| 05/03/2001 | WO2001030356A1 Hormonal composition based on a progestational agent and an oestrogen and use thereof |
| 05/03/2001 | WO2001030354A1 REGULATION OF Apob FOR DIAGNOSIS, TREATMENT AND DRUG SCREENING FOR CARDIOVASCULAR AND METABOLIC DISORDERS OR SYNDROMES |
| 05/03/2001 | WO2001030300A2 Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies |
| 05/03/2001 | WO2001016596A3 Screening for modulators of gaba b receptor activity |
| 05/03/2001 | WO2001016164A3 Treatment of allergic rhinitis |
| 05/03/2001 | WO2001005968A9 Angiocidin: a cys-ser-val-thr-cys-gly specific tumor cell adhesion receptor |
| 05/03/2001 | WO2001005812A3 PEPTIDES AND THEIR UTILITY IN MODULATION OF BEHAVIOR OF CELLS EXPRESSING α3β1 INTEGRINS |
| 05/03/2001 | WO2001001139A3 Incorporation and appliations of biomolecular interactions within a carrier |
| 05/03/2001 | WO2001000666A3 Self-aligning peptides derived from human elastin and other fibrous proteins |
| 05/03/2001 | WO2001000664A3 Secreted alpha-helical protein-36 |
| 05/03/2001 | WO2001000221A3 Therapeutic methods and compositions for the treatment of impaired interpersonal and behavioral disorders |
| 05/03/2001 | WO2000078946A3 Treatment of viral influenza with antisense oligonucleotides |
| 05/03/2001 | WO2000078802A3 Secreted polypeptides and corresponding polynucleotides |
| 05/03/2001 | WO2000077168A3 ANTAGONISTS OF BMP AND TGFβ SIGNALLING PATHWAYS |
| 05/03/2001 | WO2000076539A3 A method to improve protective immunity induced by polynucleotide vaccines |
| 05/03/2001 | WO2000075320A3 Human genes and proteins encoded thereby |
| 05/03/2001 | WO2000074712A3 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product |
| 05/03/2001 | WO2000072876A3 Prevention and treatment of amyloidogenic disease |
| 05/03/2001 | WO2000071096A3 Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases |
| 05/03/2001 | WO2000068263A3 Stereoselective antifibrillogenic peptides and peptidomimetics thereof |
| 05/03/2001 | WO2000065028A3 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR |
| 05/03/2001 | WO2000063245A3 Variant of the plasmodium merozoite surface protein (msp-1) and vaccine comprising said variant |
| 05/03/2001 | WO2000054813A3 Use of recombinant gene delivery vectors for treating or preventing diseases of the eye |
| 05/03/2001 | WO2000054785A3 Stabilized bicyclo[3.3.1]nonenes and methods of use |
| 05/03/2001 | US20010000802 Implantable system with drug-eluting cells for on-demand local drug delivery |
| 05/03/2001 | US20010000785 Attaching a bioeffecting agent to a substrate with an anchor provided by a linker compound which also forms a cleavable linkage so that the drug has a sustained release; anti-thrombogenic, -imicrobial, -inflammatory agents |
| 05/03/2001 | US20010000784 Administering a diester of an N- or N,N'-mono- or diacyl or peptidyl residue of cystine; a food, nutrient or infusion; patient in a cachectic condition; antitumor, -carcinogenic -diabetes agents; gastrointestinal inflammatory diseases |
| 05/03/2001 | US20010000783 Associated with inhibited epithelial cell proliferation comprising administering a heparin-binding epidermal growth factor-like growth factor (HB-EGF) or derivative, e,g. anantiidiotypic antibody to HB-EGF, gene therapy; angonists |
| 05/03/2001 | US20010000730 Method of enhancing the efficacy of anti-tumor agents |
| 05/03/2001 | DE19951970A1 Arzneimittel für die Toleranzinduktion Medicines for tolerance induction |
| 05/03/2001 | DE19951824A1 New N-terminal fragment of insulin-like growth factor binding protein-3 and its complexes with growth factors for treatment and diagnosis of e.g. muscular atrophy |
| 05/03/2001 | DE19951617A1 Zubereitungen pharmazeutische Wirkstoffe Preparations active pharmaceutical ingredients |
| 05/03/2001 | DE19951471A1 Verwendung von Urodilatin zur Behandlung chronischer Niereninsuffizienz mit Nierenrestfunktionen Use of Urodilatin for the treatment of chronic renal insufficiency with residual renal function |
| 05/03/2001 | DE19949436A1 New human antibiotic peptides, useful for treating microbial infections, particularly when incorporated in wound dressings, also related nucleic acid |
| 05/03/2001 | DE19949179A1 Nukleinsäuresequenzen von Hyperplasien und Tumoren der Schilddrüse Nucleic acid sequences of hyperplasias and tumors of the thyroid |
| 05/03/2001 | DE10038203A1 Implantable active agent depot, useful e.g. in local tumor treatment or gene therapy, comprising drug-containing, cubic phase forming lipid matrix containing modifier molecule to control release kinetics |
| 05/03/2001 | CA2721011A1 Modified gp100 and uses thereof |
| 05/03/2001 | CA2404438A1 Synthetic human genes and polypeptides and their use in the treatment of autoimmune diseases |
| 05/03/2001 | CA2390084A1 Novel chimeric analgesic peptides |